("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology ... San Antonio Breast Cancer Symposium being held December 10-13, at ...
News
- Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK ... - ABC4 Utah
- Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors - Quantisnow
Biotechnology: Biological Products (No Diagnostic Substances). Health Care. Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio ...
- Angle PLC Announces HER2 Presentation at SABCS - BioSpace
WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUM. Independent findings support ANGLE's HER2 assay ...
- Agendia To Unveil Enhanced Breast Cancer Therapy at San Antonio - Yahoo
By Karen Roman Agendia, Inc. said it will present data to assess treatment decisions on patients with early-stage breast cancer at the San Antonio ...
- Machine learning model predicts breast cancer treatment response - Medical Xpress
... San Antonio Breast Cancer Symposium (SABCS), held December 10–13, 2024. While the use of CDK4/6 inhibitors combined with endocrine therapy have ...